Perfil de comprador
Ministry of Social Affairs and Health
FI- Adjudicaciones
- 25
- Importe total adjudicado
- 148.258.023 €
- Países
- Finlandia
- Última adjudicación
- 6 jul 2026
- Vencen en los próximos 12 meses
- 0
Historial de adjudicaciones
| Fecha | Proveedor | Título | Categoría | Importe | País | Vence | Fuente |
|---|---|---|---|---|---|---|---|
| 06/07/2026 | Viatris Oy | Finland – Vaccines – Seasonal Influenza vaccine 2026-2027 (2027-2028) | Productos farmacéuticos | 9,7 M € | FI | — | Ver en TED ↗ |
| 26/09/2025 | GlaxoSmithKline Oy | Finland – Vaccines – Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029) | — | 2,5 M € | FI | — | Ver en TED ↗ |
| 18/09/2025 | GlaxoSmithKline Oy | Finland – Vaccines – Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029) | — | 798,3 mil € | FI | — | Ver en TED ↗ |
| 15/07/2025 | Sanofi Oy | Finland – Vaccines – Diphtheria, tetanus, pertussis and polio (DTaP + IPV) vaccine for children 2026-2027 (2028, 2029) | — | 3,5 M € | FI | — | Ver en TED ↗ |
| 20/03/2025 | Pfizer Oy | Finland – Vaccines – Tick-borne Encephalitis (TBE) Vaccine for adults and children 2025 - 2028 | — | 3,2 M € | FI | — | Ver en TED ↗ |
| 20/03/2025 | Sanofi Oy | Finland – Vaccines – Diphtheria, Tetanus and Pertussis (acellurar component) Booster (dtap) Vaccine 2025 - 2027 (2027 - 2028 and 2028 - 2029) | — | 5,0 M € | FI | — | Ver en TED ↗ |
| 02/12/2024 | Pfizer Oy | Finland – Vaccines – Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 2025-2026 and (2026-2027, 2027-2028) | Productos farmacéuticos | 13,8 M € | FI | — | Ver en TED ↗ |
| 29/11/2024 | GlaxoSmithKline Oy | Finland – Vaccines – Human Papillomavirus Vaccine (HPV) 2024-2026 (2026-2027 and 2027-2028) | — | 8,1 M € | FI | — | Ver en TED ↗ |
| 09/08/2024 | MSD Finland Oy | Finland – Vaccines – Measles, Mumps, Rubella and Varicella (MMRV) combination Vaccine 2024-2026 and (2026-2027, 2027-2028) | — | 10,7 M € | FI | — | Ver en TED ↗ |
| 09/08/2024 | MSD Finland Oy | Finland – Vaccines – Varicella vaccine 2025-2026 (2027 and 2028) | — | 8,1 M € | FI | — | Ver en TED ↗ |
| 09/08/2024 | Seqirus UK Ltd | Finland – Vaccines – Enhanced Seasonal Influenza Vaccine 2024-2025 (2025-2026, 2026-2027) | — | 6,4 M € | FI | — | Ver en TED ↗ |
| 10/04/2024 | MSD Finland Oy | Finland – Vaccines – Rotavirus vaccine 2024 - 2026 (2026 - 2028) | — | 5,8 M € | FI | — | Ver en TED ↗ |
| 09/10/2023 | Finland-Helsinki: Vaccines | — | 1,6 M € | FI | — | Ver en TED ↗ | |
| 06/10/2023 | Finland-Helsinki: Vaccines | — | 98,6 mil € | FI | — | Ver en TED ↗ | |
| 06/10/2023 | Finland-Helsinki: Vaccines | — | 300,0 mil € | FI | — | Ver en TED ↗ | |
| 22/02/2023 | Finland-Helsinki: Vaccines | — | 7,7 M € | FI | — | Ver en TED ↗ | |
| 20/02/2023 | Finland-Helsinki: Vaccines | — | 29,9 M € | FI | — | Ver en TED ↗ | |
| 23/12/2022 | Finland-Helsinki: Vaccines | — | 1,7 M € | FI | — | Ver en TED ↗ | |
| 02/12/2022 | Finland-Helsinki: Vaccines | — | 9,2 M € | FI | — | Ver en TED ↗ | |
| 19/08/2022 | Finland-Helsinki: Vaccines | — | 2,5 M € | FI | — | Ver en TED ↗ | |
| 08/08/2022 | Finland-Helsinki: Vaccines | — | 12,2 M € | FI | — | Ver en TED ↗ | |
| 10/06/2022 | Finland-Helsinki: Vaccines | — | 286,2 mil € | FI | — | Ver en TED ↗ | |
| 03/06/2022 | Finland-Helsinki: Vaccines | — | 599,9 mil € | FI | — | Ver en TED ↗ | |
| 30/05/2022 | Finland-Helsinki: Vaccines | — | 1,1 M € | FI | — | Ver en TED ↗ | |
| 09/07/2021 | Finland-Valtioneuvosto: Vaccines | — | 3,4 M € | FI | — | Ver en TED ↗ |